scholarly journals Serum amyloid A and Janus kinase 2 in a mouse model of diabetic kidney disease

PLoS ONE ◽  
2019 ◽  
Vol 14 (2) ◽  
pp. e0211555 ◽  
Author(s):  
Brad P. Dieter ◽  
Rick L. Meek ◽  
Robert J. Anderberg ◽  
Sheryl K. Cooney ◽  
Jen L. Bergin ◽  
...  
Keyword(s):  
Kidney Disease ◽  
Mouse Model ◽  
Diabetic Kidney Disease ◽  
Serum Amyloid A ◽  
Janus Kinase ◽  
Serum Amyloid ◽  
Janus Kinase 2 ◽  
Diabetic Kidney ◽  
Amyloid A

scholarly journals Serum amyloid A and inflammation in diabetic kidney disease and podocytes

2014 ◽  
Vol 95 (3) ◽  
pp. 250-262 ◽  
Author(s):  
Robert J Anderberg ◽  
Rick L Meek ◽  
Kelly L Hudkins ◽  
Sheryl K Cooney ◽  
Charles E Alpers ◽  
...  
Keyword(s):  
Kidney Disease ◽  
Diabetic Kidney Disease ◽  
Serum Amyloid A ◽  
Serum Amyloid ◽  
Diabetic Kidney ◽  
Amyloid A

scholarly journals Erratum: Serum amyloid A and inflammation in diabetic kidney disease and podocytes

2015 ◽  
Vol 95 (6) ◽  
pp. 697-697 ◽  
Author(s):  
Robert J Anderberg ◽  
Rick L Meek ◽  
Kelly L Hudkins ◽  
Sheryl K Cooney ◽  
Charles E Alpers ◽  
...  
Keyword(s):  
Kidney Disease ◽  
Diabetic Kidney Disease ◽  
Serum Amyloid A ◽  
Serum Amyloid ◽  
Diabetic Kidney ◽  
Amyloid A

scholarly journals Serum amyloid a and risk of death and end-stage renal disease in diabetic kidney disease

2016 ◽  
Vol 30 (8) ◽  
pp. 1467-1472 ◽  
Author(s):  
Brad P. Dieter ◽  
Sterling M. McPherson ◽  
Maryam Afkarian ◽  
Ian H. de Boer ◽  
Rajnish Mehrotra ◽  
...  
Keyword(s):  
Kidney Disease ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Diabetic Kidney Disease ◽  
Serum Amyloid A ◽  
Serum Amyloid ◽  
Risk Of Death ◽  
Amyloid A ◽  
Stage Renal Disease ◽  
End Stage

Sa1108 SERUM AMYLOID A PROMOTES INFLAMMATION-ASSOCIATED DAMAGE, MACROPHAGE INFILTRATION AND TUMORIGENESIS IN A MOUSE MODEL OF COLITIS-ASSOCIATED COLON CANCER

2020 ◽  
Vol 158 (6) ◽  
pp. S-278
Author(s):  
Tanja Davis ◽  
Daleen Conradie ◽  
Preetha Shridas ◽  
Marcielle C. de Beer ◽  
Frederick c. de Beer ◽  
...  
Keyword(s):  
Colon Cancer ◽  
Mouse Model ◽  
Serum Amyloid A ◽  
Serum Amyloid ◽  
Macrophage Infiltration ◽  
Amyloid A

scholarly journals The effects of type 1 IGF receptor inhibition in a mouse model of diabetic kidney disease

2011 ◽  
Vol 21 (5) ◽  
pp. 285-291 ◽  
Author(s):  
Ariel Troib ◽  
Daniel Landau ◽  
Jack F. Youngren ◽  
Leonid Kachko ◽  
Ralph Rabkin ◽  
...  
Keyword(s):  
Kidney Disease ◽  
Mouse Model ◽  
Diabetic Kidney Disease ◽  
Diabetic Kidney ◽  
Receptor Inhibition ◽  
Igf Receptor

Diabetic kidney disease in thedb/dbmouse

2003 ◽  
Vol 284 (6) ◽  
pp. F1138-F1144 ◽  
Author(s):  
Kumar Sharma ◽  
Peter McCue ◽  
Stephen R. Dunn
Keyword(s):  
Diabetic Nephropathy ◽  
Kidney Disease ◽  
Mouse Model ◽  
Renal Disease ◽  
Mouse Models ◽  
Diabetic Kidney Disease ◽  
Diabetic Kidney ◽  
Matrix Expansion ◽  
Stage Renal Disease ◽  
End Stage

Diabetic nephropathy is increasing in incidence and is now the number one cause of end-stage renal disease in the industrialized world. To gain insight into the genetic susceptibility and pathophysiology of diabetic nephropathy, an appropriate mouse model of diabetic nephropathy would be critical. A large number of mouse models of diabetes have been identified and their kidney disease characterized to various degrees. Perhaps the best characterized and most intensively investigated model is the db/ db mouse. Because this model appears to exhibit the most consistent and robust increase in albuminuria and mesangial matrix expansion, it has been used as a model of progressive diabetic renal disease. In this review, we present the findings from various studies on the renal pathology of the db/ db mouse model of diabetes in the context of human diabetic nephropathy. Furthermore, we discuss shortfalls of assessing functional renal disease in mouse models of diabetic kidney disease.

Sign in / Sign up

Export Citation Format

Share Document